Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Paul Mueller Company remains a strong buy due to compelling value, robust growth, and a pristine balance sheet. Despite a 21.8% revenue surge to $160.2M in H1 2026, net income and cash flows declined due to higher costs and one-off events. MUEL's new module fabrication building is nearly full, supporting higher workloads and mitigating the need for expensive contractors.

SPRINGFIELD, Mo., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced that its Board of Directors has declared a cash dividend of 35 cents ($0.35) per share on its outstanding common stock.

Paul Mueller's Q2 revenues jump 29% y/y, but lower margins weigh on earnings as strong pharmaceutical demand and a healthy backlog support the results.

SPRINGFIELD, Mo., July 31, 2026 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced earnings for the second quarter ended June 30, 2026.